--- title: "Enovis CORP (ENOV) stock listing, news and investor profile" url: "https://aibio.space/companies/enovis/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Enovis CORP (NYSE: ENOV), United States. Listing facts, related biotech companies and news on aibio.space." --- ENOV Enovis CORP NYSE · United States # Enovis CORP (ENOV) news Enovis CORP is a public biotech or pharmaceutical company listed on NYSE under the ticker ENOV, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Enovis CORP news We have not published a story on Enovis CORP yet. When there is news, it will appear here. ## Enovis CORP at a glance - **Ticker**: ENOV - **Listing**: NYSE - **Country**: United States - **Cash, Jul 3, 2026**: $12.6 million ### Related companies - [biote](https://aibio.space/companies/biote/) NASDAQ: BTMD - [RxSight](https://aibio.space/companies/rxsight/) NASDAQ: RXST - [ORTHOPEDIATRICS CORP](https://aibio.space/companies/orthopediatrics/) NASDAQ: KIDS - [ICU MEDICAL INC/DE](https://aibio.space/companies/icu-medical-de/) NASDAQ: ICUI - [Heartflow](https://aibio.space/companies/heartflow/) NASDAQ: HTFL - [Nok Therapeutics](https://aibio.space/companies/nok-therapeutics/) OTC: NKTPD - [AMERICAN SHARED HOSPITAL SERVICES](https://aibio.space/companies/american-shared-hospital-services/) NYSE: AMS - [Renalytix](https://aibio.space/companies/renalytix/) OTC: RNLXY ### Also on NYSE - [QUEST DIAGNOSTICS INC](https://aibio.space/companies/quest-diagnostics/) DGX - [STERIS](https://aibio.space/companies/steris/) STE - [Penumbra](https://aibio.space/companies/penumbra/) PEN - [Cadre Holdings](https://aibio.space/companies/cadre/) CDRE - [CONMED](https://aibio.space/companies/conmed/) CNMD - [Edwards Lifesciences](https://aibio.space/companies/edwards-lifesciences/) EW ## Enovis CORP annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$2.25 billion](https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/) | [$2.11 billion](https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/) | | Research and development | [$120.3 million](https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/) | [$91.3 million](https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/) | | Net income (loss) | [-$1.18 billion](https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/) | [-$825.5 million](https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/) | | Cash from operations | [$217.3 million](https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/) | [$113.5 million](https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/) | | Cash and equivalents | [$36.4 million](https://www.sec.gov/Archives/edgar/data/1420800/000142080026000035/) | [$48.2 million](https://www.sec.gov/Archives/edgar/data/1420800/000142080026000012/) | Latest balance sheet, Jul 3, 2026 (10-Q): cash and equivalents $12.6 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Enovis CORP What is the ticker symbol of Enovis CORP? Enovis CORP trades under the ticker ENOV on NYSE. Where is Enovis CORP listed? Enovis CORP is listed on NYSE. Which country or territory is Enovis CORP listed under? Our directory records Enovis CORP under United States. Does aibio.space cover Enovis CORP? aibio.space lists Enovis CORP among 2,820 public biotech companies and publishes its news here as stories appear. What was Enovis CORP's revenue last year? $2.25 billion for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is Enovis CORP profitable? Enovis CORP reported a net loss of $1.18 billion for the fiscal year ended Dec 31, 2025, and generated $217.3 million of cash from operations, per its annual report to the SEC. How much does Enovis CORP spend on research and development? $120.3 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does Enovis CORP have? $12.6 million in cash at Jul 3, 2026, per its 10-Q. ## Investor discussion: Enovis CORP Members talk about Enovis CORP (ENOV). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NYSE:ENOV on TradingView](https://www.tradingview.com/symbols/NYSE-ENOV/). ## Listing details Enovis CORP is a public biotech or pharmaceutical company listed on NYSE under the ticker ENOV, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Enovis CORP - **Ticker**: ENOV - **Listing**: NYSE - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/enovis/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Enovis CORP (ENOV) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/enovis/